471 filings
ARS
2023 FY
EVOK
Evoke Pharma Inc
10 Apr 24
Annual report to shareholders
3:36pm
DEFA14A
EVOK
Evoke Pharma Inc
10 Apr 24
Additional proxy soliciting materials
3:35pm
DEF 14A
EVOK
Evoke Pharma Inc
Definitive proxy
10 Apr 24
3:34pm
PRE 14A
EVOK
Evoke Pharma Inc
Preliminary proxy
29 Mar 24
4:03pm
424B3
EVOK
Evoke Pharma Inc
25 Mar 24
Prospectus supplement
4:56pm
8-K
vf2 l3sd30ky5hiqs
25 Mar 24
Entry into a Material Definitive Agreement
4:55pm
8-K
o7d6bd7h3qimu53q6yd
21 Mar 24
Departure of Directors or Certain Officers
4:15pm
8-K
gqdttu 3br6643t
18 Mar 24
Other Events
5:02pm
POS EX
mr7wq51xhepn
14 Mar 24
Additional exhibits for listing
6:46pm
424B3
5qljfe
14 Mar 24
Prospectus supplement
6:44pm
8-K
xs2g0in2k4 7nsj8
14 Mar 24
Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial Results
4:00pm
SC 13G
tmnssjaqz6gcu ewwka8
13 Mar 24
Evoke Pharma / LYTTON LAURENCE W ownership change
1:32pm
SC 13G
z6n26she fmh
11 Mar 24
Evoke Pharma / Bleichroeder ownership change
6:39pm
8-K
aapwakrkphkgdo
23 Feb 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
SC 13G
fxlp2pz pqx7shm
20 Feb 24
Evoke Pharma / Altium Capital Management ownership change
4:38pm
8-K
994gh0 ph
14 Feb 24
Unregistered Sales of Equity Securities
9:00am
SC 13G
xxhha9o15 nznnu6
13 Feb 24
Evoke Pharma / HIRSCHMAN ORIN ownership change
6:34am
8-K
z33pe
9 Feb 24
Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 Million
5:15pm
424B4
2dx0d4tf7l
9 Feb 24
Prospectus supplement with pricing info
5:14pm